nattokinasa

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

atherosclerosis

[Insufficient Evidence]

Dose: 10,800 fibrinolytic units PO qd; Info: used with aspirin

HTN

[Insufficient Evidence]

Dose: 2000 fibrinolytic units PO qd; Alt: 30 g extract PO qd

hyperlipidemia

[Insufficient Evidence]

Dose: 10,800 fibrinolytic units PO qd; Info: used with aspirin and vitamin K2

impaired glucose tolerance

[Insufficient Evidence]

Dose: 34 fibrinolytic units PO bid

venous insufficiency

[Insufficient Evidence]

Dose: 2000 fibrinolytic units PO qd

venous thromboembolism

[Insufficient Evidence]

Dose: 2000 fibrinolytic units PO qd; Info: start 30 days after tx with fondaparinux or enoxaparin